Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
222.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.60 (0.721%)
Market Cap: £2.27b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Board Update - Director Changes

10 Mar 2022 07:00

RNS Number : 2663E
Helios Towers PLC
10 March 2022
 

Helios Towers plc

Board Update - Director Changes

Helios Towers plc (the "Company") today announces that with effect from 9 March 2022, David Wassong has resigned as a non-executive director of the Company and has been replaced by Helis Zulijani-Boye, a Managing Director of Newlight Partners LP with over 15 years' experience in the private equity and investment banking industries.

These changes are made pursuant to the Shareholders Agreement entered into by the Company and Newlight, along with other pre-IPO investors in the Company, under which Newlight is entitled to appoint (and replace) a shareholder representative as a director of the Company for such time as it continues to hold more than 10% of the voting rights of the Company.

Commenting on the changes to the Board, Sir Sam Jonah, Chairman of Helios Towers plc said today:

"On behalf of the Board, I would like to express my thanks to David for his contribution to the success of the business. David has been a director since the creation of Helios Towers in 2010, during which time the Company has grown significantly and listed on the London Stock Exchange. We recognise the part that David played in building the business. At the same time, we are delighted to welcome Helis to the Board. She brings extensive experience which will enhance the Board and we look forward to working with her."

This announcement is made in accordance with Listing Rule 9.6.11. There are no further disclosures to be made pursuant to Listing Rule 9.6.13 in respect of Helis Zulijani-Boye's appointment.

 

Helios Towers Investor Relations:

Chris Baker-Sams, Head of Strategic Finance and Investor Relations

+44 (0)752 310 1475

investorrelations@heliostowers.com

 

Media Relations:

Edward Bridges / Stephanie Ellis

FTI Consulting LLP

+44 (0)20 3727 1000

 

 

About Helios Towers

 

· Helios Towers is a leading independent telecommunications infrastructure company, having established one of the most extensive tower portfolios across Africa. It builds, owns and operates telecom passive infrastructure, providing services to mobile network operators.

 

· Helios Towers owns and operates telecommunication tower sites in Tanzania, Democratic Republic of Congo, Congo Brazzaville, Ghana, South Africa, Senegal and Madagascar. Following recent acquisition agreements and subject to regulatory approval, Helios Towers expects to establish a presence in three new markets across Africa and the Middle-East. Including these acquisitions and committed BTS, the Group's total site count is expected to increase from over 9,000 towers to over 14,000.

 

· Helios Towers pioneered the model in Africa of buying towers that were held by single operators and providing services utilising the tower infrastructure to the seller and other operators. This allows wireless operators to outsource non-core tower-related activities, enabling them to focus their capital and managerial resources on providing higher quality services more cost-effectively.

 

For more information about Helios Towers, please visit: https://www.heliostowers.com/investors/investor-home/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUGWWUPPGRB
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20263:41 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20263:26 pmRNSTotal Voting Rights
28th May 202610:15 amRNSHolding(s) in Company
26th May 20267:00 amRNSTransaction in Own Shares
20th May 202612:13 pmRNSHolding(s) in Company
20th May 20267:00 amRNSHolding(s) in Company
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20261:10 pmRNSDirector/PDMR Shareholding
14th May 20261:12 pmRNS2026 Annual General Meeting Results
11th May 20267:37 amRNSTransaction in Own Shares
8th May 20267:11 amRNSHolding(s) in Company
7th May 20267:00 amRNSQ1 2026 Results
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20268:47 amRNSHolding(s) in Company
30th Apr 20264:03 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 202612:20 pmRNSHolding(s) in Company
8th Apr 202610:49 amRNSNotice of Q1 2026 Results Date & Conference Call
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20262:34 pmRNSTotal Voting Rights
30th Mar 20269:50 amRNSAnnual Report and Notice of AGM
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202612:00 pmRNSDirector/PDMR Shareholding
25th Mar 20266:08 pmRNSHelios Towers announces pricing of Senior Notes
24th Mar 202611:43 amRNSLAUNCH OF OFFER OF SENIOR NOTES
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20263:14 pmRNSDirector/PDMR Shareholding
16th Mar 20263:14 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFull Year Results 2025
12th Mar 20267:00 amRNSFull Year Results 2025
9th Mar 20264:15 pmRNSDirectorate change
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20264:19 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.